Search Pharmacovigilance & Regulatory Intelligence

PV teams should revise workflows and SOPs related to regulatory submissions for blood systems, ensuring alignment with new guidance on performance data, biocompatibility testing, and regulatory pathways.

Identify which unclassified medical devices are affected by the exemption; update regulatory submissions and post-market surveillance plans accordingly; ensure compliance with general controls and post-market surveillance obligations.